Genetics May Play Role In Antidepressant Birth Defect Risks: Study
The risk of birth defects when taking SSRIs during pregnancy may be increased in mothers and infants with certain genetic variations, according to the findings of a new study.
The risk of birth defects when taking SSRIs during pregnancy may be increased in mothers and infants with certain genetic variations, according to the findings of a new study.
A new study finds that SSRI antidepressants can increase the risk of brain bleeds, and that risk increases even more when certain blood thinners are taken concurrently.
Certain antidepressants, like Zoloft, Paxil and Celexa, may increase the risk of congenital heart defects and stillbirth, according to the findings of a new study.
The use of SSRI antidepressants during pregnancy can increase the risk of a child requiring care in NICU, according to the findings of a new study.
A new study warns that using SSRI antidepressants during pregnancy may increase the risk of children being born with dyslexia and other language disorders.
Nearly 300 Zoloft birth defect lawsuits were dismissed and consolidated federal proceedings ended after a federal judge ruled that plaintiffs could not prove that the antidepressant caused birth defects.
The findings of a new study indicate that children may be twice as likely to attempt suicide or become aggressive when using some antidepressants.
The CDC warns that many women of reproductive age are taking antidepressants which could cause birth defects if they get pregnant, saying more education on the risks are needed.
A new study adds to a growing body of evidence suggesting that the use of antidepressants during pregnancy may increase the risk of a child being diagnosed with autism later…
Zoloft birth defect lawsuits are again at risk, following the exclusion of an expert witness whose testimony was crucial in explaining how the antidepressant could cause heart defects among infants.